← Back to Search

Behavioral Intervention

Mobile App for Gestational Diabetes

Augusta, GA
N/A
Recruiting
Led By Rebecca Keipper, MD
Research Sponsored by Carolyn Zahler-Miller
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years and older
Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare the use of a mobile app versus traditional paper logs in monitoring blood sugar levels in pregnant women with diabetes. The goal is to see if using a mobile app can help improve compliance

See full description
Who is the study for?
This trial is for pregnant women who are at least 12 weeks along, with a confirmed intrauterine pregnancy, aged 18 or older. Participants must be diagnosed with either type 2 diabetes mellitus or gestational diabetes.Check my eligibility
What is being tested?
The study is examining the impact of using the OneTouch Reveal mobile app versus traditional paper logs to track blood sugar levels in pregnant women with diabetes and how it affects their compliance and control over blood sugar.See study design
What are the potential side effects?
Since this trial involves using a mobile app for logging data, there are no direct medical side effects. However, participants may experience inconvenience or technical issues related to the use of the app.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
 show original
Select...
I have been diagnosed with type 2 or gestational diabetes.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Compliance
Secondary study objectives
Percentage of in-range blood glucose levels

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile App armExperimental Treatment1 Intervention
Patient will input their daily blood glucose levels (fasting and 2 hours after breakfast, lunch and dinner) into the OneTouch Reveal app
Group II: Paper Log ArmActive Control1 Intervention
Patients will input their daily blood glucose levels onto paper logs which is the current process in the prenatal clinic.

Find a Location

Closest Location:Augusta University· Augusta, GA

Who is running the clinical trial?

Carolyn Zahler-MillerLead Sponsor
Rebecca Keipper, MDPrincipal InvestigatorAugusta University
~27 spots leftby Jan 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top